(EMAILWIRE.COM, July 25, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Long-acting Drug Delivery Technologies Services Market Size, Share & Trends Analysis Report By Technique (Long-Acting Injectables, Long-Acting Hydrogels, Long-Acting Implants, Long-Acting Microneedles, And Nanocrystal Suspensions), Dosage Form (Injectables, Implantable, Topical/Transdermal, Vaginal), Type Of Molecule Delivered (Small Molecules, Biologics), Material Used (Polymer Based And Non-Polymer Based) And End-User (Biopharmaceutical And Life Science Companies And Research And Academics), Region, Market Outlook And Industry Analysis 2031”
Download Free Demo Report: https://www.insightaceanalytic.com/request-sample/2565
Long-acting drug delivery is a novel method of drug delivery that enables a drug to retain its full therapeutic effect for weeks, months, or years following a single administration and to preserve its optimal therapeutic level in the patient’s body. In the past two decades, the pharmaceutical industry has undergone a paradigm shift from established drug delivery strategies to the long-acting drug delivery of products to treat a variety of disease indications, including ophthalmic disorders, oncological disorders, neurological disorders, and infectious diseases. The long-acting delivery of drug candidates offers an array of benefits, including increased patient compliance, a reduced dosage requirement, enhanced medication adherence, a reduced risk of failure due to inconsistent utilization, and increased patient convenience. The pharmaceutical and healthcare sectors are significantly affected by the industry impact of long-acting drug delivery technologies and services. A substantial impact is observed in patient outcomes and adherence. Improved patient adherence is facilitated by the implementation of long-acting drug delivery systems, which necessitate less frequent administration, thereby decreasing the probability of missed doses and increasing the overall efficacy of the treatment. This favorable effect on patient outcomes not only improves the quality of healthcare but also has the potential to decrease the costs associated with untreated or suboptimally treated conditions.
List of Prominent Players in the Long-acting Drug Delivery Technologies Services Market:
Adare Pharma Solutions
AMW
Bostal Drug Delivery
Creative Biolabs
For Doz Pharma
Innocore Pharmaceuticals
Integral BioSystems
LATITUDE Pharmaceuticals
Navin Saxena Research and Technology Centre (NSRT)
Samyang Biopharm
Market Dynamics:
Drivers-
Increasing adoption of sustained-release drugs and related technologies is the main driver for global growth. Another driver for market growth is a rise in the prevalence of chronic diseases, necessitating more efficient drug delivery systems. Technological advancements that pave the way for innovative drug formulations also fuel the Long-acting drug delivery technologies services market. Integration of biologics and biosimilars into long-acting drug delivery systems is also responsible for driving the market.
Challenges:
Despite the positive drivers, the market is confronted with a variety of challenges, such as potential limitations resulting from the delayed onset of action of specific therapeutics. The potential for delayed onset of action is one of the primary limitations, which restricts their use in situations that necessitate rapid therapeutic effects. Scepticism regarding the long-term efficacy and safety of the product impedes its market adoption.
Regional Trends:
The Asia Pacific long-acting drug delivery technologies services market is anticipated to register a significant industry share in terms of revenue. It is expected that a considerable compound annual growth rate (CAGR) will be experienced in the near future. The long-acting drug delivery technologies and services market in the Asia-Pacific region is undergoing substantial development, which is characterized by a changing healthcare landscape, technological advancements, and an increase in demand. This growth is indicative of a convergence of factors that have contributed to the adoption and expansion of long-acting drug delivery solutions across a variety of therapeutic areas. This is a result of the major participants in the Long-acting Drug Delivery Technologies Services market adopting new strategies. Furthermore, the global long-acting drug delivery technologies services market is poised for growth due to the growing collaboration among major players and the presence of key market players in the region aiming to penetrate the market.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2565
Recent Developments:
In May 2024, DURECT Corporation revealed that larsucosterol has been received Breakthrough Therapy designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of patients with severe alcohol-associated hepatitis (AH). The Phase 2b AHFIRM trial, a double-blind, placebo-controlled, international, multi-center study that assessed the safety and efficacy of larsucosterol as a treatment for patients with severe AH, provides clinical evidence that supports the BTD.
Segmentation of Long-acting Drug Delivery Technologies Services Market-
By Technique-
Long-Acting Injectables
Long-Acting Hydrogels
Long-Acting Implants
Long-Acting Microneedles
Nanocrystal Suspensions
By Dosage Form-
Injectables
Implantable
Topical/Transdermal
Vaginal
Other Dosage Forms
By Type of Molecule Delivered-
Small Molecules
Biologics
Other Molecules
By Material Used-
Polymer Based
Non-Polymer Based
By End User-
Biopharmaceutical and Life science Companies
Research and Academics
By Region-
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/2565
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
